We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Xi'an Tianlong Science & Technology Co., Ltd

Tianlong is an innovative, high-technology company that provides professional PCR detection devices, reagent kits and... read more Featured Products: More products

Download Mobile App





Tianlong Showcases Cutting-Edge Products and Innovative Molecular Diagnostic Solutions

By LabMedica International staff writers
Posted on 13 Nov 2023

Tianlong Science and Technology (Shaanxi, China) is showcasing its cutting-edge products and innovative molecular diagnostic solutions at MEDICA 2023. More...

The company is also highlighting its classic integrated PCR lab solution and its brand new product - Panall 8000 All-in-One Molecular Diagnosis System at the show. The revolutionary Panall 8000 All-in-One Molecular Diagnosis System seamlessly integrates various diagnostic stages, setting new standards for efficiency and accuracy in the field of molecular diagnostics.

Tianlong is also exhibiting the RBT320 Agglutination Automated Detection System which is intended for the detection of Brucellosis based on the Rose Bengal Test (RBT) method. Designed for automating laboratory workflow, Tianlong RBT320 integrates various functions, including automatic sample loading, sample mixing, photographing, AI image recognition, and result interpretation. With optimized efficiency, RBT320 can process 320 samples per hour and is suitable for large-scale screening of Brucella antibodies. Tianlong RBT320 is highly automated and can empower labs with maximum efficiency and effectively avoid human errors, while the use of the RBT method can also be cost-effective for labs.

At MEDICA 2023, Tianlong is also presenting the iGeneCase 1600 Diagnostics-in-a-Suitcase, and PANA 9600X Automated Nucleic Acid Workstation, as well as a variety of products and compatible reagents. For instance, Tianlong's solution for nucleic acid detection of influenza virus is designed to identify and differentiate various strains, including Influenza A/B, Influenza C, Influenza A(H1&H3), Influenza A(H1N1), Influenza A(H3N2), and Influenza A(H5N1), as well as multiplex kit for Influenza A/B/Human Adenovirus/2019-nCoV. This comprehensive solution provides a scientific basis for accurate diagnosis and treatment of individuals with symptoms of influenza.

Related Links:
Tianlong Science and Technology


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Gold Member
Platelet Function Analyzer
PL-12
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers from the Department of Chemistry at Aarhus University have developed and tested a new technology that can identify and measure the concentration of pharmaceuticals in under 10 minutes. Today, this process takes up to an hour. That is critical waiting time for patients suffering from a stroke. (Image Credit: Aarhus University)

Point-of-Care Blood Test Could Speed Treatment Decisions in Acute Stroke

Minutes can shape treatment decisions in emergency stroke care, particularly when physicians need to know whether a patient is taking anticoagulants before administering clot-dissolving therapy.... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.